Cellectar Biosciences, Inc. Share Price
Cellectar Biosciences, Inc. (CLRB) had Share Price of $2.50 per share as of 2019-05-20, per its 10-K filed 2021-03-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2021-03-02
- 2019-05-20: Share Price $2.50.
- 2018-07-31: Share Price $10000.00; Share Price as first filed $4.00.
- 2017-07-31: Share Price $4.00.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2019-05-20 | $2.50 10-K · filed 2021-03-02 | |
| 2018-07-31 | $10000.00 10-K · filed 2020-03-09 | $4.00 10-K · filed 2019-02-26 |
| 2017-07-31 | $4.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |